About Solon Ventures Limited
Solon is a venture capital firm based in the UK that invests in the healthcare and technology sectors.
We provide support and capital to entrepreneurs to develop businesses across all stages of development.
Solon's approach is based on dedication, partnership and integrity.
On 15th June 2015, Circassia Pharmaceuticals (LSE: CIRL) announced the acquisition of Solon Ventures portfolio company Prosonix Limited.
On 7th July 2014, Concept Life Sciences announced the acquisition of Solon Ventures portfolio company Peakdale Molecular Limited.
On 15th April 2014, Prosonix Limited announced that it had entered into a global licensing agreement with Mylan Inc. (Nasdaq: MYL), one of the world's leading global pharmaceutical companies, for its leading inhaled respiratory products, PSX1001 and PSX1050.